Corrigendum to "Tumor Necrosis Factor-α-Dependent Inflammation Upregulates High Mobility Group Box 1 To Induce Tumor Promotion and Anti-Programmed Cell Death Protein-1 Immunotherapy Resistance in Lung Adenocarcinoma" [Laboratory Investigation 105 (2025) 102164]

Lifei Kang¹, Jingjing Cao², Wenli Guo³, Xiaohui Cui⁴, Yangxuan Wei⁵, Jiayu Zhang⁵, Feiran Liu⁶, Chenyang Duan⁴, Qiang Lin⁷, Ping Lvx⁸, Zhiyu Ni⁹, Jing Zuo¹⁰, Haitao Shen¹¹

Affiliations

¹ Laboratory of Pathology, Hebei Medical University, Shijiazhuang, China; Department of Pathology, Hebei Chest Hospital, Shijiazhuang, China.
² Laboratory of Pathology, Hebei Medical University, Shijiazhuang, China; Center of Metabolic Diseases and Cancer Research, Hebei Medical University, Shijiazhuang, China; Department of Pathology, Lishui Central Hospital of Zhejiang Province, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
³ Laboratory of Pathology, Hebei Medical University, Shijiazhuang, China; Department of Pathology, The Second Hospital, Hebei Medical University, Shijiazhuang, China.
⁴ Laboratory of Pathology, Hebei Medical University, Shijiazhuang, China; Center of Metabolic Diseases and Cancer Research, Hebei Medical University, Shijiazhuang, China.
⁵ Center of Metabolic Diseases and Cancer Research, Hebei Medical University, Shijiazhuang, China.
⁶ Department of Oncology, The Fourth Hospital, Hebei Medical University, Shijiazhuang, China.
⁷ Department of Oncology, North China Petroleum Bureau General Hospital of Hebei Medical University, Renqiu, China.
⁸ Department of Pharmacology, Hebei Medical University, Shijiazhuang, China.
⁹ Affiliated Hospital of Hebei University of Engineering, Handan, China; Clinical Medical College, Hebei University of Engineering, Handan, China; Hebei Collaborative Innovation Center of Tumor Microecological Metabolism Regulation, Affiliated Hospital of Hebei University, Baoding, China. Electronic address: nizhiyu@hebeu.edu.cn.
¹⁰ Center of Metabolic Diseases and Cancer Research, Hebei Medical University, Shijiazhuang, China; Department of Oncology, The Fourth Hospital, Hebei Medical University, Shijiazhuang, China; Hebei Collaborative Innovation Center of Tumor Microecological Metabolism Regulation, Affiliated Hospital of Hebei University, Baoding, China. Electronic address: wdh970916@hebmu.edu.cn.
¹¹ Laboratory of Pathology, Hebei Medical University, Shijiazhuang, China; Center of Metabolic Diseases and Cancer Research, Hebei Medical University, Shijiazhuang, China; Hebei Collaborative Innovation Center of Tumor Microecological Metabolism Regulation, Affiliated Hospital of Hebei University, Baoding, China. Electronic address: haitaoshen78@hebmu.edu.cn.

PMID: 41043304
DOI: 10.1016/j.labinv.2025.104228

Published Erratum

Corrigendum to "Tumor Necrosis Factor-α-Dependent Inflammation Upregulates High Mobility Group Box 1 To Induce Tumor Promotion and Anti-Programmed Cell Death Protein-1 Immunotherapy Resistance in Lung Adenocarcinoma" [Laboratory Investigation 105 (2025) 102164]

Lifei Kang et al. Lab Invest. 2025.

. 2025 Oct 2;105(11):104228.

doi: 10.1016/j.labinv.2025.104228. Online ahead of print.

Authors

Lifei Kang¹, Jingjing Cao², Wenli Guo³, Xiaohui Cui⁴, Yangxuan Wei⁵, Jiayu Zhang⁵, Feiran Liu⁶, Chenyang Duan⁴, Qiang Lin⁷, Ping Lvx⁸, Zhiyu Ni⁹, Jing Zuo¹⁰, Haitao Shen¹¹

Affiliations

¹ Laboratory of Pathology, Hebei Medical University, Shijiazhuang, China; Department of Pathology, Hebei Chest Hospital, Shijiazhuang, China.
² Laboratory of Pathology, Hebei Medical University, Shijiazhuang, China; Center of Metabolic Diseases and Cancer Research, Hebei Medical University, Shijiazhuang, China; Department of Pathology, Lishui Central Hospital of Zhejiang Province, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
³ Laboratory of Pathology, Hebei Medical University, Shijiazhuang, China; Department of Pathology, The Second Hospital, Hebei Medical University, Shijiazhuang, China.
⁴ Laboratory of Pathology, Hebei Medical University, Shijiazhuang, China; Center of Metabolic Diseases and Cancer Research, Hebei Medical University, Shijiazhuang, China.
⁵ Center of Metabolic Diseases and Cancer Research, Hebei Medical University, Shijiazhuang, China.
⁶ Department of Oncology, The Fourth Hospital, Hebei Medical University, Shijiazhuang, China.
⁷ Department of Oncology, North China Petroleum Bureau General Hospital of Hebei Medical University, Renqiu, China.
⁸ Department of Pharmacology, Hebei Medical University, Shijiazhuang, China.
⁹ Affiliated Hospital of Hebei University of Engineering, Handan, China; Clinical Medical College, Hebei University of Engineering, Handan, China; Hebei Collaborative Innovation Center of Tumor Microecological Metabolism Regulation, Affiliated Hospital of Hebei University, Baoding, China. Electronic address: nizhiyu@hebeu.edu.cn.
¹⁰ Center of Metabolic Diseases and Cancer Research, Hebei Medical University, Shijiazhuang, China; Department of Oncology, The Fourth Hospital, Hebei Medical University, Shijiazhuang, China; Hebei Collaborative Innovation Center of Tumor Microecological Metabolism Regulation, Affiliated Hospital of Hebei University, Baoding, China. Electronic address: wdh970916@hebmu.edu.cn.
¹¹ Laboratory of Pathology, Hebei Medical University, Shijiazhuang, China; Center of Metabolic Diseases and Cancer Research, Hebei Medical University, Shijiazhuang, China; Hebei Collaborative Innovation Center of Tumor Microecological Metabolism Regulation, Affiliated Hospital of Hebei University, Baoding, China. Electronic address: haitaoshen78@hebmu.edu.cn.

PMID: 41043304
DOI: 10.1016/j.labinv.2025.104228

No abstract available

PubMed Disclaimer

Erratum for

Tumor Necrosis Factor-α-Dependent Inflammation Upregulates High Mobility Group Box 1 To Induce Tumor Promotion and Anti-Programmed Cell Death Protein-1 Immunotherapy Resistance in Lung Adenocarcinoma.
Kang L, Cao J, Guo W, Cui X, Wei Y, Zhang J, Liu F, Duan C, Lin Q, Lv P, Ni Z, Zuo J, Shen H. Kang L, et al. Lab Invest. 2025 Feb;105(2):102164. doi: 10.1016/j.labinv.2024.102164. Epub 2024 Oct 24. Lab Invest. 2025. PMID: 39461427

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "Tumor Necrosis Factor-α-Dependent Inflammation Upregulates High Mobility Group Box 1 To Induce Tumor Promotion and Anti-Programmed Cell Death Protein-1 Immunotherapy Resistance in Lung Adenocarcinoma" [Laboratory Investigation 105 (2025) 102164]

Affiliations

Corrigendum to "Tumor Necrosis Factor-α-Dependent Inflammation Upregulates High Mobility Group Box 1 To Induce Tumor Promotion and Anti-Programmed Cell Death Protein-1 Immunotherapy Resistance in Lung Adenocarcinoma" [Laboratory Investigation 105 (2025) 102164]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Research Materials